<?xml version="1.0" encoding="UTF-8"?>
<ref id="bph15164-bib-0020">
 <mixed-citation publication-type="journal" id="bph15164-cit-0021">
  <string-name>
   <surname>Levy</surname>, 
   <given-names>B. D.</given-names>
  </string-name>, 
  <string-name>
   <surname>Lukacs</surname>, 
   <given-names>N. W.</given-names>
  </string-name>, 
  <string-name>
   <surname>Berlin</surname>, 
   <given-names>A. A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Schmidt</surname>, 
   <given-names>B.</given-names>
  </string-name>, 
  <string-name>
   <surname>Guilford</surname>, 
   <given-names>W. J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Serhan</surname>, 
   <given-names>C. N.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Parkinson</surname>, 
   <given-names>J. F.</given-names>
  </string-name> (
  <year>2007</year>). 
  <article-title>Lipoxin A
   <sub>4</sub> stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism
  </article-title>. 
  <source xml:lang="en">The FASEB Journal.</source>, 
  <volume>21</volume>, 
  <fpage>3877</fpage>â€“
  <lpage>3884</lpage>. 
  <pub-id pub-id-type="doi">10.1096/fj.07-8653com</pub-id>
  <pub-id pub-id-type="pmid">17625069</pub-id>
 </mixed-citation>
</ref>
